Summary hazard ratios (HRs) and 95% confidence intervals (CIs) of epithelial ovarian cancer OS for BRCA dysfunction status.

Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study

Girardi, Fabio
Barnes, Daniel
Barrowdale, Daniel
Frost, Debra
Brady, Angela
Miller, Claire
Donaldson, Alan
Murray, Alex
Brewer, Carole
Pottinger, Caroline
Evans, Gareth
Eccles, Diana
Lalloo, Fiona
Gregory, Helen
Cook, Jackie
Eason, Jacqueline
Adlard, Julian
Barwell, Julian
Ong, Kai-Ren
Walker, Lisa
Izatt, Louise
Side, Lucy E.
Kennedy, M. John
Tischkowitz, Marc
Rogers, Mark T.
Tischkowitz, Marc
Rogers, Mark T.
Porteous, Mary E.
Morrison, Patrick J.
Eeles, Ros
Davidson, Rosemarie
Snape, Katie
Easton, Douglas F.
Antoniou, Antonis C.
EMBRACE

PurposeBRCA1/BRCA2 predictive test negatives are proven non-carriers of a BRCA1/BRCA2 mutation that ...

Hazard ratios, P value, and heterogeneity for PFS and OS in the stratified analyses.

Xunlei Zhang (451325)
Chunxiang Cao (451327)
Qi Zhang (28502)
Yi Chen (38576)
Dongying Gu (337113)
Yunzhu Shen (505124)
Yongling Gong (459871)
Jinfei Chen (222979)
Cuiju Tang (451330)

January 2014

HR, hazard ratio; PH, heterogeneity P; GC, gastric cancer; CRC, colorect...

Ovarian Cancer Risk Factors by Histologic Subtype : An Analysis From the Ovarian Cancer Cohort Consortium

Wentzensen, Nicolas
Poole, Elizabeth M
Trabert, Britton
White, Emily
Arslan, Alan A
Patel, Alpa V
Setiawan, V Wendy
Visvanathan, Kala
Weiderpass, Elisabete
Adami, Hans-Olov
Black, Amanda
Bernstein, Leslie
Brinton, Louise A
Buring, Julie
Butler, Lesley M
Chamosa, Saioa
Clendenen, Tess V
Dossus, Laure
Fortner, Renee
Gapstur, Susan M
Gaudet, Mia M
Gram, Inger T
Hartge, Patricia
Hoffman-Bolton, Judith
Idahl, Annika
Jones, Michael
Kaaks, Rudolf
Kirsh, Victoria
Koh, Woon-Puay
Lacey, James V
Lee, I-Min
Lundin, Eva
Merritt, Melissa A
Onland-Moret, N Charlotte
Peters, Ulrike
Poynter, Jenny N
Rinaldi, Sabina
Robien, Kim
Rohan, Thomas
Sandler, Dale P
Schairer, Catherine
Schouten, Leo J
Sjöholm, Louise K
Sieri, Sabina
Swerdlow, Anthony
Tjonneland, Anna
Travis, Ruth
Trichopoulou, Antonia
van den Brandt, Piet A
Wilkens, Lynne
Wolk, Alicja
Yang, Hannah P
Zeleniuch-Jacquotte, Anne
Tworoger, Shelley S

August 2016

PURPOSE: An understanding of the etiologic heterogeneity of ovarian cancer is important for improvin...

Summary hazard ratios (HRs) and 95% confidence intervals (CIs) of ovarian cancer PFS for BRCA dysfunction status.

Chaoyang Sun (558189)
Na Li (6550)
Dong Ding (112949)
Danhui Weng (558190)
Li Meng (136180)
Gang Chen (107840)
Ding Ma (115288)

May 2014

Horizontal lines represent 95% CIs; diamonds represent summary estimates with corresponding 95% C...

Subgroup meta-analysis of summary hazard ratios (HRs) and 95% confidence intervals (CIs) of ovarian cancer OS for different BRCA mutation statuses.

Chaoyang Sun (558189)
Na Li (6550)
Dong Ding (112949)
Danhui Weng (558190)
Li Meng (136180)
Gang Chen (107840)
Ding Ma (115288)

May 2014

A: BRCA1 mutation. B: BRCA2 mutation. Horizontal lines represent 95% CIs; diamonds ...

Univariate and multivariate Coxs proportional hazard ratio in 220 ovarian cancer patients.

Cinzia Baranello (313262)
Marisa Mariani (313263)
Mirko Andreoli (313264)
Mara Fanelli (313266)
Enrica Martinelli (63992)
Gabriella Ferrandina (63990)
Giovanni Scambia (14643)
Shohreh Shahabi (313271)
Cristiano Ferlini (255998)

February 2013

CI = confidence interval; HR = hazards ratio;*HR was calculated Stage III vs. Stage I-II;*...

Probability of ovarian cancer survival for patients that have lower grade (I and II) tumors (black lines) or higher (Rest) grade tumors (gray lines) and high (dashed lines) or low (solid line) levels of hsa-miR-521.

Kristin R. Delfino (388573)
Sandra L. Rodriguez-Zas (19332)

March 2013

Probability of ovarian cancer survival for patients that have lower grade (I and II) tumors (blac...

Hazard ratios (HRs) with 95% confidence intervals (CIs) for (A) age at menarche (per 1 year increase) on overall survival (OS) and (B) duration of endogenous estrogen exposure (per 1 year increase), (C) number of children ≥4 vs. 2, and (D) number of years since last birth <5 vs. ≥20 years on disease-free survival (DFS) of breast cancer by intrinsic subtypes.

Nan Song (118617)
Ji-Yeob Choi (181377)
Hyuna Sung (181373)
Sujee Jeon (721072)
Seokang Chung (606330)
Minkyo Song (723444)
Sue K. Park (127433)
Wonshik Han (6448)
Jong Won Lee (287967)
Mi Kyung Kim (181391)
Keun-Young Yoo (127429)
Sei-Hyun Ahn (153880)
Dong-Young Noh (6456)
Daehee Kang (6451)

April 2015

aI-squared describes the percentage of the variability in effect estimates that is due...

Relative risk of ovarian cancer by tumour histology.

Collaborative Group on Epidemiological Studies of Ovarian Cancer (614232)

April 2012

Relative risk1 (RR1) is stratified by study, age at diagnosis, parity, meno...

Hazard ratios, P value, and heterogeneity for ORR and DCR in the stratified analyses.

Xunlei Zhang (451325)
Chunxiang Cao (451327)
Qi Zhang (28502)
Yi Chen (38576)
Dongying Gu (337113)
Yunzhu Shen (505124)
Yongling Gong (459871)
Jinfei Chen (222979)
Cuiju Tang (451330)

January 2014

HR, hazard ratio; PH, heterogeneity P; GC, gastric cancer; CRC, colorect...

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Barnes, Daniel
Rookus, Matti
Mcguffog, Lesley
Leslie, Goska
Mooij, Thea
Dennis, Joe
Mavaddat, Nasim
Adlard, Julian
Ahmed, Munaza
Aittomäki, Kristiina
Andrieu, Nadine
Andrulis, Irene
Arnold, Norbert
Arun, Banu
Azzollini, Jacopo
Balmaña, Judith
Barkardottir, Rosa
Barrowdale, Daniel
Benitez, Javier
Berthet, Pascaline
Białkowska, Katarzyna
Blanco, Amie
Blok, Marinus
Bonanni, Bernardo
Boonen, Susanne
Borg, Åke
Bozsik, Aniko
Bradbury, Angela
Brennan, Paul
Brewer, Carole
Brunet, Joan
Buys, Saundra
Caldés, Trinidad
Caligo, Maria
Campbell, Ian
Christensen, Lise Lotte
Chung, Wendy
Claes, Kathleen
Colas, Chrystelle
Collonge-Rame, Marie-Agnès
Cook, Jackie
Daly, Mary
Davidson, Rosemarie
de La Hoya, Miguel
de Putter, Robin
Delnatte, Capucine
Devilee, Peter
Diez, Orland
Ding, Yuan Chun
Domchek, Susan
Dorfling, Cecilia
Dumont, Martine
Eeles, Ros
Ejlertsen, Bent
Engel, Christoph
Evans, D Gareth
Faivre, Laurence
Foretova, Lenka
Fostira, Florentia
Friedlander, Michael
Friedman, Eitan
Frost, Debra
Ganz, Patricia
Garber, Judy
Gehrig, Andrea
Gerdes, Anne-Marie
Gesta, Paul
Giraud, Sophie
Glendon, Gord
Godwin, Andrew
Goldgar, David
González-Neira, Anna
Greene, Mark
Gschwantler-Kaulich, Daphne
Hahnen, Eric
Hamann, Ute
Hanson, Helen
Hentschel, Julia
Hogervorst, Frans
Hooning, Maartje
Horvath, Judit
Hu, Chunling
Hulick, Peter
Imyanitov, Evgeny
Isaacs, Claudine
Izatt, Louise
Izquierdo, Angel
Jakubowska, Anna
James, Paul
Janavicius, Ramunas
John, Esther
Joseph, Vijai
Karlan, Beth
Kast, Karin
Koudijs, Marco
Kruse, Torben
Kwong, Ava
Laitman, Yael
Lasset, Christine
Lazaro, Conxi
Lester, Jenny
Lesueur, Fabienne
Liljegren, Annelie
Loud, Jennifer
Lubiński, Jan
Mai, Phuong
Manoukian, Siranoush
Mari, Véronique
Mebirouk, Noura
Meijers-Heijboer, Hanne
Meindl, Alfons
Mensenkamp, Arjen
Miller, Austin
Montagna, Marco
Mouret-Fourme, Emmanuelle
Mukherjee, Semanti
Mulligan, Anna Marie
Nathanson, Katherine
Neuhausen, Susan
Nevanlinna, Heli
Niederacher, Dieter
Nielsen, Finn Cilius
Nikitina-Zake, Liene
Nogues, Catherine, C.
Olah, Edith
Olopade, Olufunmilayo
Ong, Kai-Ren
O'Shaughnessy-Kirwan, Aoife
Osorio, Ana
Ott, Claus-Eric
Papi, Laura
Park, Sue
Parsons, Michael
Pedersen, Inge Sokilde
Peissel, Bernard
Peixoto, Ana
Peterlongo, Paolo
Pfeiler, Georg
Phillips, Kelly-Anne
Prajzendanc, Karolina
Pujana, Miquel Angel
Radice, Paolo
Ramser, Juliane
Ramus, Susan
Rantala, Johanna
Rennert, Gad
Risch, Harvey
Robson, Mark
Rønlund, Karina
Salani, Ritu
Schuster, Hélène
Senter, Leigha
Shah, Payal
Sharma, Priyanka
Side, Lucy
Singer, Christian
Slavin, Thomas
Soucy, Penny
Southey, Melissa
Spurdle, Amanda
Steinemann, Doris
Steinsnyder, Zoe
Stoppa-Lyonnet, Dominique
Sutter, Christian
Tan, Yen Yen
Teixeira, Manuel
Teo, Soo Hwang
Thull, Darcy
Tischkowitz, Marc
Tognazzo, Silvia
Toland, Amanda
Trainer, Alison
Tung, Nadine
van Engelen, Klaartje
van Rensburg, Elizabeth
Vega, Ana
Vierstraete, Jeroen
Wagner, Gabriel
Walker, Lisa
Wang-Gohrke, Shan
Wappenschmidt, Barbara
Weitzel, Jeffrey
Yadav, Siddhartha
Yang, Xin
Yannoukakos, Drakoulis
Zimbalatti, Dario
Offit, Kenneth
Thomassen, Mads
Couch, Fergus
Schmutzler, Rita
Simard, Jacques
Easton, Douglas
Chenevix-Trench, Georgia
Antoniou, Antonis

October 2020

International audienceWe assessed the associations between population-based polygenic risk scores (P...

Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study.

Girardi, F. [et al]
Brewer, Carole

March 2018

PurposeBRCA1/BRCA2 predictive test negatives are proven noncarriers of a BRCA1/BRCA2 mutation that i...

Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study

Girardi, Fabio
Barnes, Daniel
Barrowdale, Daniel
Frost, Debra
Brady, Angela
Miller, Claire
Donaldson, Alan
Murray, Alex
Brewer, Carole
Pottinger, Caroline
Evans, Gareth
Eccles, Diana
Lalloo, Fiona
Gregory, Helen
Cook, Jackie
Eason, Jacqueline
Adlard, Julian
Barwell, Julian
Ong, Kai-Ren
Walker, Lisa
Izatt, Louise
Side, Lucy E.
Kennedy, M. John
Tischkowitz, Marc
Rogers, Mark T.
Tischkowitz, Marc
Rogers, Mark T.
Porteous, Mary E.
Morrison, Patrick J.
Eeles, Ros
Davidson, Rosemarie
Snape, Katie
Easton, Douglas F.
Antoniou, Antonis C.
EMBRACE

PurposeBRCA1/BRCA2 predictive test negatives are proven non-carriers of a BRCA1/BRCA2 mutation that ...

Hazard ratios, P value, and heterogeneity for PFS and OS in the stratified analyses.

Xunlei Zhang (451325)
Chunxiang Cao (451327)
Qi Zhang (28502)
Yi Chen (38576)
Dongying Gu (337113)
Yunzhu Shen (505124)
Yongling Gong (459871)
Jinfei Chen (222979)
Cuiju Tang (451330)

January 2014

HR, hazard ratio; PH, heterogeneity P; GC, gastric cancer; CRC, colorect...

Ovarian Cancer Risk Factors by Histologic Subtype : An Analysis From the Ovarian Cancer Cohort Consortium

Wentzensen, Nicolas
Poole, Elizabeth M
Trabert, Britton
White, Emily
Arslan, Alan A
Patel, Alpa V
Setiawan, V Wendy
Visvanathan, Kala
Weiderpass, Elisabete
Adami, Hans-Olov
Black, Amanda
Bernstein, Leslie
Brinton, Louise A
Buring, Julie
Butler, Lesley M
Chamosa, Saioa
Clendenen, Tess V
Dossus, Laure
Fortner, Renee
Gapstur, Susan M
Gaudet, Mia M
Gram, Inger T
Hartge, Patricia
Hoffman-Bolton, Judith
Idahl, Annika
Jones, Michael
Kaaks, Rudolf
Kirsh, Victoria
Koh, Woon-Puay
Lacey, James V
Lee, I-Min
Lundin, Eva
Merritt, Melissa A
Onland-Moret, N Charlotte
Peters, Ulrike
Poynter, Jenny N
Rinaldi, Sabina
Robien, Kim
Rohan, Thomas
Sandler, Dale P
Schairer, Catherine
Schouten, Leo J
Sjöholm, Louise K
Sieri, Sabina
Swerdlow, Anthony
Tjonneland, Anna
Travis, Ruth
Trichopoulou, Antonia
van den Brandt, Piet A
Wilkens, Lynne
Wolk, Alicja
Yang, Hannah P
Zeleniuch-Jacquotte, Anne
Tworoger, Shelley S

August 2016

PURPOSE: An understanding of the etiologic heterogeneity of ovarian cancer is important for improvin...

Summary hazard ratios (HRs) and 95% confidence intervals (CIs) of ovarian cancer PFS for BRCA dysfunction status.

Chaoyang Sun (558189)
Na Li (6550)
Dong Ding (112949)
Danhui Weng (558190)
Li Meng (136180)
Gang Chen (107840)
Ding Ma (115288)

May 2014

Horizontal lines represent 95% CIs; diamonds represent summary estimates with corresponding 95% C...

Subgroup meta-analysis of summary hazard ratios (HRs) and 95% confidence intervals (CIs) of ovarian cancer OS for different BRCA mutation statuses.

Chaoyang Sun (558189)
Na Li (6550)
Dong Ding (112949)
Danhui Weng (558190)
Li Meng (136180)
Gang Chen (107840)
Ding Ma (115288)

May 2014

A: BRCA1 mutation. B: BRCA2 mutation. Horizontal lines represent 95% CIs; diamonds ...

Univariate and multivariate Coxs proportional hazard ratio in 220 ovarian cancer patients.

Cinzia Baranello (313262)
Marisa Mariani (313263)
Mirko Andreoli (313264)
Mara Fanelli (313266)
Enrica Martinelli (63992)
Gabriella Ferrandina (63990)
Giovanni Scambia (14643)
Shohreh Shahabi (313271)
Cristiano Ferlini (255998)

February 2013

CI = confidence interval; HR = hazards ratio;*HR was calculated Stage III vs. Stage I-II;*...

Probability of ovarian cancer survival for patients that have lower grade (I and II) tumors (black lines) or higher (Rest) grade tumors (gray lines) and high (dashed lines) or low (solid line) levels of hsa-miR-521.

Kristin R. Delfino (388573)
Sandra L. Rodriguez-Zas (19332)

March 2013

Probability of ovarian cancer survival for patients that have lower grade (I and II) tumors (blac...

Hazard ratios (HRs) with 95% confidence intervals (CIs) for (A) age at menarche (per 1 year increase) on overall survival (OS) and (B) duration of endogenous estrogen exposure (per 1 year increase), (C) number of children ≥4 vs. 2, and (D) number of years since last birth <5 vs. ≥20 years on disease-free survival (DFS) of breast cancer by intrinsic subtypes.

Nan Song (118617)
Ji-Yeob Choi (181377)
Hyuna Sung (181373)
Sujee Jeon (721072)
Seokang Chung (606330)
Minkyo Song (723444)
Sue K. Park (127433)
Wonshik Han (6448)
Jong Won Lee (287967)
Mi Kyung Kim (181391)
Keun-Young Yoo (127429)
Sei-Hyun Ahn (153880)
Dong-Young Noh (6456)
Daehee Kang (6451)

April 2015

aI-squared describes the percentage of the variability in effect estimates that is due...

Relative risk of ovarian cancer by tumour histology.

Collaborative Group on Epidemiological Studies of Ovarian Cancer (614232)

April 2012

Relative risk1 (RR1) is stratified by study, age at diagnosis, parity, meno...

Hazard ratios, P value, and heterogeneity for ORR and DCR in the stratified analyses.

Xunlei Zhang (451325)
Chunxiang Cao (451327)
Qi Zhang (28502)
Yi Chen (38576)
Dongying Gu (337113)
Yunzhu Shen (505124)
Yongling Gong (459871)
Jinfei Chen (222979)
Cuiju Tang (451330)

January 2014

HR, hazard ratio; PH, heterogeneity P; GC, gastric cancer; CRC, colorect...

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Barnes, Daniel
Rookus, Matti
Mcguffog, Lesley
Leslie, Goska
Mooij, Thea
Dennis, Joe
Mavaddat, Nasim
Adlard, Julian
Ahmed, Munaza
Aittomäki, Kristiina
Andrieu, Nadine
Andrulis, Irene
Arnold, Norbert
Arun, Banu
Azzollini, Jacopo
Balmaña, Judith
Barkardottir, Rosa
Barrowdale, Daniel
Benitez, Javier
Berthet, Pascaline
Białkowska, Katarzyna
Blanco, Amie
Blok, Marinus
Bonanni, Bernardo
Boonen, Susanne
Borg, Åke
Bozsik, Aniko
Bradbury, Angela
Brennan, Paul
Brewer, Carole
Brunet, Joan
Buys, Saundra
Caldés, Trinidad
Caligo, Maria
Campbell, Ian
Christensen, Lise Lotte
Chung, Wendy
Claes, Kathleen
Colas, Chrystelle
Collonge-Rame, Marie-Agnès
Cook, Jackie
Daly, Mary
Davidson, Rosemarie
de La Hoya, Miguel
de Putter, Robin
Delnatte, Capucine
Devilee, Peter
Diez, Orland
Ding, Yuan Chun
Domchek, Susan
Dorfling, Cecilia
Dumont, Martine
Eeles, Ros
Ejlertsen, Bent
Engel, Christoph
Evans, D Gareth
Faivre, Laurence
Foretova, Lenka
Fostira, Florentia
Friedlander, Michael
Friedman, Eitan
Frost, Debra
Ganz, Patricia
Garber, Judy
Gehrig, Andrea
Gerdes, Anne-Marie
Gesta, Paul
Giraud, Sophie
Glendon, Gord
Godwin, Andrew
Goldgar, David
González-Neira, Anna
Greene, Mark
Gschwantler-Kaulich, Daphne
Hahnen, Eric
Hamann, Ute
Hanson, Helen
Hentschel, Julia
Hogervorst, Frans
Hooning, Maartje
Horvath, Judit
Hu, Chunling
Hulick, Peter
Imyanitov, Evgeny
Isaacs, Claudine
Izatt, Louise
Izquierdo, Angel
Jakubowska, Anna
James, Paul
Janavicius, Ramunas
John, Esther
Joseph, Vijai
Karlan, Beth
Kast, Karin
Koudijs, Marco
Kruse, Torben
Kwong, Ava
Laitman, Yael
Lasset, Christine
Lazaro, Conxi
Lester, Jenny
Lesueur, Fabienne
Liljegren, Annelie
Loud, Jennifer
Lubiński, Jan
Mai, Phuong
Manoukian, Siranoush
Mari, Véronique
Mebirouk, Noura
Meijers-Heijboer, Hanne
Meindl, Alfons
Mensenkamp, Arjen
Miller, Austin
Montagna, Marco
Mouret-Fourme, Emmanuelle
Mukherjee, Semanti
Mulligan, Anna Marie
Nathanson, Katherine
Neuhausen, Susan
Nevanlinna, Heli
Niederacher, Dieter
Nielsen, Finn Cilius
Nikitina-Zake, Liene
Nogues, Catherine, C.
Olah, Edith
Olopade, Olufunmilayo
Ong, Kai-Ren
O'Shaughnessy-Kirwan, Aoife
Osorio, Ana
Ott, Claus-Eric
Papi, Laura
Park, Sue
Parsons, Michael
Pedersen, Inge Sokilde
Peissel, Bernard
Peixoto, Ana
Peterlongo, Paolo
Pfeiler, Georg
Phillips, Kelly-Anne
Prajzendanc, Karolina
Pujana, Miquel Angel
Radice, Paolo
Ramser, Juliane
Ramus, Susan
Rantala, Johanna
Rennert, Gad
Risch, Harvey
Robson, Mark
Rønlund, Karina
Salani, Ritu
Schuster, Hélène
Senter, Leigha
Shah, Payal
Sharma, Priyanka
Side, Lucy
Singer, Christian
Slavin, Thomas
Soucy, Penny
Southey, Melissa
Spurdle, Amanda
Steinemann, Doris
Steinsnyder, Zoe
Stoppa-Lyonnet, Dominique
Sutter, Christian
Tan, Yen Yen
Teixeira, Manuel
Teo, Soo Hwang
Thull, Darcy
Tischkowitz, Marc
Tognazzo, Silvia
Toland, Amanda
Trainer, Alison
Tung, Nadine
van Engelen, Klaartje
van Rensburg, Elizabeth
Vega, Ana
Vierstraete, Jeroen
Wagner, Gabriel
Walker, Lisa
Wang-Gohrke, Shan
Wappenschmidt, Barbara
Weitzel, Jeffrey
Yadav, Siddhartha
Yang, Xin
Yannoukakos, Drakoulis
Zimbalatti, Dario
Offit, Kenneth
Thomassen, Mads
Couch, Fergus
Schmutzler, Rita
Simard, Jacques
Easton, Douglas
Chenevix-Trench, Georgia
Antoniou, Antonis

October 2020

International audienceWe assessed the associations between population-based polygenic risk scores (P...

Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study.

Girardi, F. [et al]
Brewer, Carole

March 2018

PurposeBRCA1/BRCA2 predictive test negatives are proven noncarriers of a BRCA1/BRCA2 mutation that i...

Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study

Girardi, Fabio
Barnes, Daniel
Barrowdale, Daniel
Frost, Debra
Brady, Angela
Miller, Claire
Donaldson, Alan
Murray, Alex
Brewer, Carole
Pottinger, Caroline
Evans, Gareth
Eccles, Diana
Lalloo, Fiona
Gregory, Helen
Cook, Jackie
Eason, Jacqueline
Adlard, Julian
Barwell, Julian
Ong, Kai-Ren
Walker, Lisa
Izatt, Louise
Side, Lucy E.
Kennedy, M. John
Tischkowitz, Marc
Rogers, Mark T.
Tischkowitz, Marc
Rogers, Mark T.
Porteous, Mary E.
Morrison, Patrick J.
Eeles, Ros
Davidson, Rosemarie
Snape, Katie
Easton, Douglas F.
Antoniou, Antonis C.
EMBRACE

PurposeBRCA1/BRCA2 predictive test negatives are proven non-carriers of a BRCA1/BRCA2 mutation that ...

Hazard ratios, P value, and heterogeneity for PFS and OS in the stratified analyses.

Xunlei Zhang (451325)
Chunxiang Cao (451327)
Qi Zhang (28502)
Yi Chen (38576)
Dongying Gu (337113)
Yunzhu Shen (505124)
Yongling Gong (459871)
Jinfei Chen (222979)
Cuiju Tang (451330)

January 2014

HR, hazard ratio; PH, heterogeneity P; GC, gastric cancer; CRC, colorect...

Ovarian Cancer Risk Factors by Histologic Subtype : An Analysis From the Ovarian Cancer Cohort Consortium

Wentzensen, Nicolas
Poole, Elizabeth M
Trabert, Britton
White, Emily
Arslan, Alan A
Patel, Alpa V
Setiawan, V Wendy
Visvanathan, Kala
Weiderpass, Elisabete
Adami, Hans-Olov
Black, Amanda
Bernstein, Leslie
Brinton, Louise A
Buring, Julie
Butler, Lesley M
Chamosa, Saioa
Clendenen, Tess V
Dossus, Laure
Fortner, Renee
Gapstur, Susan M
Gaudet, Mia M
Gram, Inger T
Hartge, Patricia
Hoffman-Bolton, Judith
Idahl, Annika
Jones, Michael
Kaaks, Rudolf
Kirsh, Victoria
Koh, Woon-Puay
Lacey, James V
Lee, I-Min
Lundin, Eva
Merritt, Melissa A
Onland-Moret, N Charlotte
Peters, Ulrike
Poynter, Jenny N
Rinaldi, Sabina
Robien, Kim
Rohan, Thomas
Sandler, Dale P
Schairer, Catherine
Schouten, Leo J
Sjöholm, Louise K
Sieri, Sabina
Swerdlow, Anthony
Tjonneland, Anna
Travis, Ruth
Trichopoulou, Antonia
van den Brandt, Piet A
Wilkens, Lynne
Wolk, Alicja
Yang, Hannah P
Zeleniuch-Jacquotte, Anne
Tworoger, Shelley S

August 2016

PURPOSE: An understanding of the etiologic heterogeneity of ovarian cancer is important for improvin...

Summary hazard ratios (HRs) and 95% confidence intervals (CIs) of epithelial ovarian cancer OS for BRCA dysfunction status.

Abstract

Extracted data

Summary hazard ratios (HRs) and 95% confidence intervals (CIs) of epithelial ovarian cancer OS for BRCA dysfunction status.

Abstract

Extracted data

Related items

Related items